Future Directions in Idiopathic Pulmonary Fibrosis Research. An NHLBI Workshop Report
Timothy S. Blackwell(University of Michigan), Jerry P. Eu(National Heart Lung and Blood Institute), Dean Sheppard(University of California, San Francisco), Imre Noth(University of Virginia), Robin R. Deterding(Robin Medical (United States)), Kevin R. Flaherty(University of Michigan), James S. Hagood(University of North Carolina at Chapel Hill), Andrew M. Tager(Harvard University), Ganesh Raghu(University of Washington), Jeffrey C. Horowitz(Lung Institute), Bethany B. Moore(University of Michigan), Erica L. Herzog(Yale University), Shelia M. Violette(Biogen (United States)), Harold A. Chapman(University of California, San Francisco), Thomas H. Sisson(Pulmonary and Critical Care Associates), Luis A. Ortiz(University of California, San Francisco), Zea Borok(UC San Diego Health System), Kevin K. Brown(Health Protection Surveillance Centre), Daniel J. Tschumperlin(WinnMed), Christine Kim Garcia(NewYork–Presbyterian Hospital), Rebecca G. Wells(And Technology Research (United Kingdom)), Craig A. Henke(University of Minnesota), Peter B. Bitterman(University of Minnesota), Eric S. White(Boehringer Ingelheim (United Kingdom)), Talmadge E. King(University of California, San Francisco), Ziv Bar‐Joseph(Carnegie Mellon University), James E. Loyd(Pulmonary and Allergy Associates), Gregory P. Cosgrove(National Jewish Health), Ramona L. Doyle(Roche (Switzerland)), Michael R. Blackburn(Arkansas Children's Nutrition Center), Harold R. Collard(University of California, San Francisco), Tim D. Oury(University of Pittsburgh), Kevin J. Anstrom(University of North Carolina at Chapel Hill), Julie Olsson(Roche (United States)), Paul W. Noble(Cedars-Sinai Medical Center), Cory M. Hogaboam(Cedars-Sinai Medical Center), Victor J. Thannickal(Tulane University), Thomas A. Wynn(National Institute of Allergy and Infectious Diseases), Patricia J. Sime(Virginia Commonwealth University), Naftali Kaminski(Yale University), David A. Schwartz(Perinatal Institute), Fernando J. Martínez(University of Massachusetts Chan Medical School), William Bradford, William E. Lawson(VA Tennessee Valley Healthcare System), Clay B. Marsh(West Virginia University), Jesse Roman(Thomas Jefferson University), Timothy E. Weaver(Perinatal Institute), Thomas G. O’Riordan(Trinity College Dublin)
American Journal of Respiratory and Critical Care Medicine
October 25, 2013
Cited by 247
Related Papers
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
|European Respiratory Journal|2004|4.4k
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
Clinical Characteristics of Covid-19 in New York City
|New England Journal of Medicine|2020|2.4k